0,1,2,3,4,5,6
Table 1. Characteristics of patients included in this study,,,,,,
,,,,,,Transmission
Patient,Age/,Case,Disease,,,Source
no.,sex,type,severity,Underlying disease,Generation,patient
14,35/M,Patient,Severe,None,2nd,1
48,37/M,Caregiver,Moderate,None,3rd,14
50,80/F,Patient,Severe,Posterior cerebral artery,3rd,14
,,,,infarction,,
61,55/M,Caregiver,Severe,None,3rd,14
62,30/M,HCW,Mild,None,3rd,14
66,42/F,Patient,Moderate,Myelodysplastic syndrome,3rd,14
68,54/F,Caregiver,Moderate,None,3rd,14
75,62/M,Patient,Moderate,Rectal cancer,3rd,14
77,63/M,Patient,Severe,Necrotizing pancreatitis,3rd,14
78,41/F,HCW,Moderate,None,3rd,14
80,34/M,Patient,Severe,Malignant lymphoma,3rd,14
99,47/M,Caregiver,Moderate,None,3rd,14
100,32/F,Patient,Moderate,Neuroendocrine tumor,3rd,14
101,84/M,Patient,Severe,Renal cell carcinoma,3rd,14
102,48/F,Patient,Moderate,None,3rd,14
103,65/M,Patient,Moderate,Middle cerebral artery,3rd,14
,,,,infarction,,
134,67/F,Patient,Mild,None,3rd,14
135,32/M,HCW,Severe,None,3rd,14
155,42/F,Patient,Mild,Hypertrophic,3rd,14
,,,,cardiomyopathy,,
157,59/M,Patient,Severe,Lung cancer,3rd,14
162,32/M,HCW,Severe,None,4th,135
164,35/F,HCW,Moderate,None,4th,135
169,33/M,HCW,Moderate,None,4th,135
177,49/F,Patient,Severe,Malignant lymphoma,3rd,14
